Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer

被引：0
|
作者：
Matthias Lang
Thomas Longerich
Chrysanthi Anamaterou
机构：
[1] University Hospital Heidelberg,Department of General
[2] University Hospital Heidelberg,, Visceral
[3] University of Heidelberg, and Transplant Surgery
来源：
Thyroid Research | / 16卷
关键词：
Anaplastic thyroid carcinoma; Vemurafenib; BRAF-inhibitor; Adjuvant targeted therapy; BRAF(V600E)-mutation; Review;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] BRAF V600E Mutation and Papillary Thyroid Cancer Reply
    Cappola, Anne R.
    Mandel, Susan J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (05): : 535 - 536
  • [22] BRAF(V600E) mutation and the biology of papillary thyroid cancer
    Frasca, F.
    Nucera, C.
    Pellegriti, G.
    Gangemi, P.
    Attard, M.
    Stella, M.
    Loda, M.
    Vella, V.
    Giordano, C.
    Trimarchi, F.
    Mazzon, E.
    Belfiore, A.
    Vigneri, R.
    ENDOCRINE-RELATED CANCER, 2008, 15 (01) : 191 - 205
  • [23] A Patient With BRAF V600E Lung Adenocarcinoma Responding to Vemurafenib
    Gautschi, Oliver
    Pauli, Chantal
    Strobel, Klaus
    Hirschmann, Astrid
    Printzen, Gert
    Aebi, Stefan
    Diebold, Joachim
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (10) : E23 - E24
  • [24] BRAF V600E Mutational Status in Pediatric Thyroid Cancer
    Henke, Lauren E.
    Perkins, Stephanie M.
    Pfeifer, John D.
    Ma, Changquing
    Chen, Yumei
    DeWees, Todd
    Grigsby, Perry W.
    PEDIATRIC BLOOD & CANCER, 2014, 61 (07) : 1168 - 1172
  • [25] Successful Treatment of a Progressive BRAF V600E-Mutated Anaplastic Pleomorphic Xanthoastrocytoma With Vemurafenib Monotherapy
    Lee, Eudocia Q.
    Ruland, Sandra
    LeBoeuf, Nicole R.
    Wen, Patrick Y.
    Santagata, Sandro
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (10) : E87 - E89
  • [26] Rapid response of biallelic BRAF V600E mutated hairy cell leukaemia to low dose vemurafenib
    Follows, George A.
    Sims, Hannah
    Bloxham, David M.
    Zenz, Thorsten
    Hopper, Melanie A.
    Liu, Hongxiang
    Bench, Anthony
    Wright, Penny
    van't Veer, Mars B.
    Scott, Mike A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 (01) : 150 - 153
  • [27] The BRAF V600E mutation is a predictor of the effect of radioiodine therapy in papillary thyroid cancer
    Ge, Junshang
    Wang, Jie
    Wang, Hui
    Jiang, Xianjie
    Liao, Qianjin
    Gong, Qian
    Mo, Yongzhen
    Li, Xiaoling
    Li, Guiyuan
    Xiong, Wei
    Zhao, Jin
    Zeng, Zhaoyang
    JOURNAL OF CANCER, 2020, 11 (04): : 932 - 939
  • [28] Concurrent BRAF V600E mutated papillary thyroid carcinoma and Erdheim–Chester disease
    Michele Klain
    Martin Schlumberger
    Alberto Cuocolo
    Endocrine, 2020, 70 : 655 - 656
  • [29] Anaplastic Pilocytic Astrocytoma of the Cerebellum with a BRAF V600E Mutation
    Baisre, Ada
    Agarwal, Nitin
    Seth, Anjali
    Liu, James
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2014, 73 (06): : 636 - 636
  • [30] BRAF V600E and lymph node metastases in papillary thyroid cancer
    Chen, Pan
    Pan, Liqin
    Huang, Wensi
    Feng, Huijuan
    Ouyang, Wei
    Wu, Juqing
    Wang, Jing
    Deng, Yuying
    Luo, Jiaxin
    Chen, Yanying
    ENDOCRINE CONNECTIONS, 2020, 9 (10) : 999 - 1008
12345